Knowledge, attitude and practices about pharmacovigilance and adverse drug reactions among dental research assistants in a Turkish hospital: a cross-sectional study
Abstract
Objective: This study was aimed to assess pharmacovigilance and adverse drug reactions knowledge, attitudes and practices of dental research assistants.
Material and Method: A cross-sectional survey was conducted in a teaching hospital at Cukurova University, Adana, Turkey, for one month. All the registered dental research assistants were invited to participate in the study. Data collection was carried out through the self-administered and validated questionnaire. The final data was analyzed by using SPSS version 21.0 (IBM, Armonk, NY, USA). Descriptive statistics such as frequencies and percentages have been determined.
Results: The questionnaire was completed by invited participants with a response rate of 92.5%. Male (n=30, 60%) was more than female (n=20, 40%) with an average age of 27.44 (SD± 2.32) years. None of the participants received pharmacovigilance training in the last 1 year. The majority of participants (60%) were unable to define pharmacovigilance and only 20% (n=10) of the dentists have correctly defined ADRs. The Most of respondents (90%) recognize ADR reporting as a professional obligation and sixty percent (n=30) perceived that the reporting of serious and unexpected ADRs are mandatory. The participants perceived that difficulties during filling of ADR forms, loss of timing and lack of information on pharmacovigilance are the main reason for the under-reporting of ADRs. Moreover, all dentists reported that they did not observe serious/severe ADRs, and 40% (n=20) reported not asking about ADR history while interacting with a patient for the first time during their practice.
Conclusion: The current study demonstrated a lack of awareness and knowledge of pharmacovigilance and ADR among dental research assistants. The inclusion of pharmacovigilance literature in the education program is mandatory and pre-and post-graduate training should be provided to dentists for rational practices.
Supporting Institution
None.
Project Number
Not applicable
References
- International society of pharmacovigilance. 18th ISoP Annual Meeting “Pharmacovigilance without borders” Geneva, Switzerland, 11–14 November, 2018. Drug Safety 2018; 41: 1103-273.
- Özcan G, Aykaç E, Kasap Y, Nemutlu NT, Sen E, Aydınkarahaliloğlu ND. Adverse drug reaction reporting pattern in Turkey: analysis of the national database in the context of the first pharmacovigilance legislation. Drugs-real world outcomes 2016; 3: 33-43.
- Ithnin M, Rani MDM, Latif ZA, et al. Mobile app design, development and publication for adverse drug reaction assessments of causality, severity and preventability. JMIR Mhealth Uhealth 2017; 5: e78.
- Güner MD, Ekmekci PE. Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. J Drug Assess 2019; 8: 13-20.
- Alshakka M, Bahattab OA, Ali H, et al. Comparison of the knowledge and perception of pharmacovigilance among pharmacy, dental and medical students in Aden-Yemen. J Pharm Pract Community Med 2017; 3: 254-61.
- Khan SA, Goyal C, Tonpay SD. A study of knowledge, attitudes, and practice of dental doctors about adverse drug reaction reporting in a teaching hospital in India. Perspect Clin Res 2015; 6: 144-9.
- Sivadasan S, Sellappan M. A study on the awareness and attitude towards pharmacovigilance and adverse drug reaction reporting among nursing students in a private university, Malaysia. Int J Current Pharm Res 2015; 7: 84-9.
- Farha RA, Alsous M, Elayeh E, Hattab D. A cross-sectional study on knowledge and perceptions of pharmacovigilance among pharmacy students of selected tertiary institutions in Jordan. Trop J Pharm Res 2015; 14: 1899-905.
- Khan MU, Ahmad A, Ejaz A, et al. Comparison of the knowledge, attitudes, and perception of barriers regarding adverse drug reaction reporting between pharmacy and medical students in Pakistan. J Educ Eval Health Prof 2015; 12: 28.
- Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007; 63: 136‑47.
- Mersha AG. Attitude and perception of medical interns about antimicrobial resistance: a multi-center cross-sectional study in Ethiopia. Antimicrob Resist Infect Control 2018; 7: 149.
- Yip J, Radford DR, Brown D. How do UK dentists deal with adverse drug reaction reporting? Br Dent J 2013; 214: e22.
- Shalini S, Mohan S. Knowledge and attitude towards pharmacovigilance and adverse drug reaction reporting among dental students in a private university, Malaysia. J Young Pharm 2015; 7: 118-25.
- Ergün Y, Ergün TB, Toker E, Ünal E, Akben M. Knowledge attitude and practice of Turkish health professionals towards pharmacovigilance in a university hospital. Int Health 2019; 11: 177-84. doi:10.1093/inthealth/ihy073.
- Karataş Y, Pelit A. Yeni çıkan ilaçların güvenlik (farmakovijilans) açısından izlenmesinin önemi [Translate: Importance of monitoring new drugs in terms of security (pharmacovigilance)]. Arşiv Kaynak Tarama Derg 2018; 27: 500-6.
- Sharma S, Khanal T, Shrestha S, Adhikari B. A celebration of world pharmacist day 2018 focusing to strengthen the pharmacy services at an oncology-based hospital in Nepal: Inspiration for others in developing countries. Res Social Adm Pharm 2019; 15: 117–8.
Abstract
Project Number
Not applicable
References
- International society of pharmacovigilance. 18th ISoP Annual Meeting “Pharmacovigilance without borders” Geneva, Switzerland, 11–14 November, 2018. Drug Safety 2018; 41: 1103-273.
- Özcan G, Aykaç E, Kasap Y, Nemutlu NT, Sen E, Aydınkarahaliloğlu ND. Adverse drug reaction reporting pattern in Turkey: analysis of the national database in the context of the first pharmacovigilance legislation. Drugs-real world outcomes 2016; 3: 33-43.
- Ithnin M, Rani MDM, Latif ZA, et al. Mobile app design, development and publication for adverse drug reaction assessments of causality, severity and preventability. JMIR Mhealth Uhealth 2017; 5: e78.
- Güner MD, Ekmekci PE. Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. J Drug Assess 2019; 8: 13-20.
- Alshakka M, Bahattab OA, Ali H, et al. Comparison of the knowledge and perception of pharmacovigilance among pharmacy, dental and medical students in Aden-Yemen. J Pharm Pract Community Med 2017; 3: 254-61.
- Khan SA, Goyal C, Tonpay SD. A study of knowledge, attitudes, and practice of dental doctors about adverse drug reaction reporting in a teaching hospital in India. Perspect Clin Res 2015; 6: 144-9.
- Sivadasan S, Sellappan M. A study on the awareness and attitude towards pharmacovigilance and adverse drug reaction reporting among nursing students in a private university, Malaysia. Int J Current Pharm Res 2015; 7: 84-9.
- Farha RA, Alsous M, Elayeh E, Hattab D. A cross-sectional study on knowledge and perceptions of pharmacovigilance among pharmacy students of selected tertiary institutions in Jordan. Trop J Pharm Res 2015; 14: 1899-905.
- Khan MU, Ahmad A, Ejaz A, et al. Comparison of the knowledge, attitudes, and perception of barriers regarding adverse drug reaction reporting between pharmacy and medical students in Pakistan. J Educ Eval Health Prof 2015; 12: 28.
- Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007; 63: 136‑47.
- Mersha AG. Attitude and perception of medical interns about antimicrobial resistance: a multi-center cross-sectional study in Ethiopia. Antimicrob Resist Infect Control 2018; 7: 149.
- Yip J, Radford DR, Brown D. How do UK dentists deal with adverse drug reaction reporting? Br Dent J 2013; 214: e22.
- Shalini S, Mohan S. Knowledge and attitude towards pharmacovigilance and adverse drug reaction reporting among dental students in a private university, Malaysia. J Young Pharm 2015; 7: 118-25.
- Ergün Y, Ergün TB, Toker E, Ünal E, Akben M. Knowledge attitude and practice of Turkish health professionals towards pharmacovigilance in a university hospital. Int Health 2019; 11: 177-84. doi:10.1093/inthealth/ihy073.
- Karataş Y, Pelit A. Yeni çıkan ilaçların güvenlik (farmakovijilans) açısından izlenmesinin önemi [Translate: Importance of monitoring new drugs in terms of security (pharmacovigilance)]. Arşiv Kaynak Tarama Derg 2018; 27: 500-6.
- Sharma S, Khanal T, Shrestha S, Adhikari B. A celebration of world pharmacist day 2018 focusing to strengthen the pharmacy services at an oncology-based hospital in Nepal: Inspiration for others in developing countries. Res Social Adm Pharm 2019; 15: 117–8.
Details
| Primary Language | English |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Original Article |
| Authors | |
| Project Number | Not applicable |
| Publication Date | October 22, 2020 |
| Published in Issue | Year 2020 Volume: 3 Issue: 4 |
Cite
Cited By
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
|
|
|
| |
|
|
|
|
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
|
|
|
|
|
|
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.